The transcript of the chairman’s address to the Annual General Meeting of Shareholders, for the financial year ending December 2020, is now available.
Please click to review the transcript at ASX.
Home » Chairman’s Address to the Annual General Meeting
The transcript of the chairman’s address to the Annual General Meeting of Shareholders, for the financial year ending December 2020, is now available.
Please click to review the transcript at ASX.
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal
MELBOURNE and SAN DIEGO — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, announced that the
https://youtu.be/LI18OcgM9XM Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent Imagion Biosystems
We’re on a mission to make cancer more detectable.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance